Lesanne Life
Sciences is
a stroke diagnostics
company that
is developing
a proprietary
protein biomarker
for the rapid
diagnosis of
CNS ischemia resulting from stroke, transient ischemic attacks
("TIAs"), lacunar infarcts, traumatic brain injury ("TBI"),
myocardial infarction, and coronary artery bypass graft ("CABG")
surgery.
|
||||
|
|||||||||||||||||||||||||
|
|||||||||||||||||||||||||
